Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

ProTmune

Cell therapy · developed by Fate Therapeutics

Phase 1/2 Most advanced trial (none active)
FATE Developer
1 Registered trials

What is ProTmune?

ProTmune is an ex-vivo, programmed cell therapy made from mobilized peripheral blood cells. It is studied in hematologic malignancies, including acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes and chronic myelogenous leukemia, and in acute graft-versus-host disease.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Cell therapy
Therapy area
Oncology
Developer
Fate Therapeutics (FATE)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1/2

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT02743351 Phase 1/2 Hematologic Malignancies Completed FATE

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Acute Graft-versus-host DiseaseAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myelogenous LeukemiaHematologic MalignanciesMyelodysplastic Syndromes

More from Fate Therapeutics

Sources

Updated Nov 15, 2026. Something wrong or missing? Report it on the FATE page.

Follow FATE, the company behind ProTmune

See FATE's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

FATE catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.